[1] Szostak JW, Blackburn EH. Cloning yeast telomeres on linear plasmid vectors[J]. Cell, 1982, 29(1):245-255
 [2] Biffi G, Tannahill D, McCafferty J, et al. Quantitative visualization of DNA G-quadruplex structures in human cells[J]. Nat Chem, 2013,5(3): 182-186
 [3] Chiba K, Johnson JZ, Vogan JM, et al. Cancer-associated TERT promoter mutations abrogate telomerase silencing[J]. Elife, 2015, 4.doi:10.7554/eLife.07918
 [4] Terali K, Yilmazer A. New surprises from an old favourite: The emergence of telomerase as a key player in the regulation of cancer stemness[J]. Biochimie, 2016, 121: 170-178
 [5] Zuo QP, Liu SK, Li ZJ, et al. NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG2 hepatoma cell line[J]. Eur J Pharmacol, 2011, 672(1-3): 113-120
 [6] Kirkpatrick KL, Newbold RF, Mokbel K. The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression[J]. J Carcinog, 2004, 3(1): 1
 [7] Koh CM, Khattar E, Leow SC, et al. Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity[J]. J Clin Invest, 2015, 125(5): 2109-2122
 [8] Xie L, Gazin C, Park SM, et al. A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells[J]. PLoS Genet, 2012, 8(12): e1003151
 [9] Zhou L, Zheng D, Wang M, et al. Telomerase reverse transcriptase activates the expression of vascular endothelial growth factor independent of telomerase activity[J]. Biochem Biophys Res Commun, 2009, 386(4): 739-743
[10] Ding D, Xi P, Zhou J, et al. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription[J]. FASEB J, 2013, 27(11): 4375-4383
[11] Ghosh A, Saginc G, Leow SC, et al. Telomerase directly regulates NF-κB-dependent transcription[J]. Nat Cell Biol, 2012, 14(12): 1270-1281
[12] Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation[J]. Nat Cell Biol, 2003, 5(5): 474-479
[13] Perrault SD, Hornsby PJ, Betts DH. Global gene expression response to telomerase in bovine adrenocortical cells[J]. Biochem Biophys Res Commun, 2005, 335(3): 925-936
[14] Lindvall C, Hou M, Komurasaki T, et al. Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene[J]. Cancer Res, 2003, 63(8): 1743-1747
[15] Park JI, Venteicher AS, Hong JY, et al. Telomerase modulates Wnt signalling by association with target gene chromatin[J]. Nature, 2009, 460(7251): 66-72
[16] Liu T, Liang X, Li B, et al. Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects[J]. Br J Cancer, 2013, 108(11): 2272-2280
[17] Ponnala S, Chetty C, Veeravalli KK, et al. MMP-9 silencing regulates hTERT expression via β1 integrin- mediated FAK signaling and induces senescence in glioma xenograft cells[J]. Cell Signal, 2011, 23(12): 2065- 2075
[18] Liu L, Liu C, Lou F, et al. Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells[J]. J Pathol, 2011, 225(2): 203-211
[19] Wu XQ, Huang C, He X, et al. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer[J]. Cell Signal, 2013, 25(12): 2462-2468
[20] Yu P, Shen X, Yang W, et al. ZEB1 stimulates breast cancer growth by up-regulating hTERT expression[J]. Biochem Biophys Res Commun, 2018, 495(4): 2505-2511
[21] Yin L, Hubbard AK, Giardina C. NF-kappa B regulates transcription of the mouse telomerase catalytic subunit[J]. J Biol Chem, 2000, 275(47): 36671-36675
[22] Hoffmeyer K, Raggioli A, Rudloff S, et al. Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells[J]. Science, 2012, 336(6088): 1549-1554
[23] Fragoso MA, Patel AK, Nakamura RE, et al. The Wnt/β-catenin pathway cross-talks with STAT3 signaling to regulate survival of retinal pigment epithelium cells[J]. PLoS One, 2012, 7(10): e46892
[24] Shay JW, Bacchetti S. A survey of telomerase activity in human cancer[J]. Eur J Cancer, 1997, 33(5): 787-791
[25] Choi J, Southworth LK, Sarin KY, et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program[J]. PLoS Genet, 2008, 4(1): e10
[26] Hrdlicková R, Nehyba J, Bose HR Jr. Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation[J]. Mol Cell Biol, 2012, 32(21): 4283-4296
[27] Geserick C, Tejera A, González-Suárez E, et al. Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling[J]. Oncogene, 2006, 25(31): 4310-4319
[28] Beck S, Jin X, Sohn YW, et al. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression[J]. Mol Cells, 2011, 31(1): 9-15
[29] Singhapol C, Pal D, Czapiewski R, et al. Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis[J]. PLoS One, 2013, 8(1): e52989
[30] Indran IR, Hande MP, Pervaiz S. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells[J]. Cancer Res, 2011, 71(1): 266-276
[31] Liu Z, Li Q, Li K, et al. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells[J]. Oncogene, 2013, 32(36): 4203-4213
[32] Liu X, Bishop J, Shan Y, et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers[J]. Endocr Relat Cancer, 2013, 20(4): 603-610
[33] Tang B, Xie R, Qin Y, et al. Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression[J]. Oncotarget, 2016, 7(10): 11364-11379
[34] Park YP, Choi SC, Kim JH, et al. Up-regulation of Mac-2 binding protein by hTERT in gastric cancer[J]. Int J Cancer, 2007, 120(4): 813-820
[35] Hu C, Ni Z, Li BS, et al. hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation[J]. Gut, 2017, 66(1): 31-42
[36] Choi MJ, Cho KH, Lee S, et al. hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness[J]. Oncogene, 2015, 34(26): 3402-3412
[37] Qin Y, Tang B, Hu CJ, et al. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer[J]. Oncotarget, 2016, 7(1): 351-361
[38] Yu YF, Zhang Y, Shen N, et al. Effect of VEGF, P53 and telomerase on angiogenesis of gastric carcinoma tissue[J]. Asian Pac J Trop Med, 2014, 7(4): 293-296
[39] Yang J, Nagavarapu U, Relloma K, et al. Telomerized human microvasculature is functional in vivo[J]. Nat Biotechnol, 2001, 19(3): 219-224
[40] Yang S, Li J, Chen Y, et al. MicroRNA-216a promotes M1 macrophages polarization and atherosclerosis progression by activating telomerase via the Smad3/NF-κB pathway[J]. Biochim Biophys Acta, 2018, pii: S0925-4439(18)30220-5
[41] Falchetti ML, Mongiardi MP, Fiorenzo P, et al. Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts[J]. Int J Cancer, 2008, 122(6): 1236-1242
[42] George J, Banik NL, Ray SK. Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma[J]. Clin Cancer Res, 2009, 15(23): 7186-7195
[43] Liu N, Ding D, Hao W, et al. hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor[J]. Nucleic Acids Res, 2016, 44(18): 8693-8703
[44] Shao N, Chen LH, Ye RY, et al. The depletion of interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells[J]. Biochem Biophys Res Commun, 2013, 431(3): 535-541
[45] Wu S, Shang H, Cui L, et al. Targeted blockade of interleukin-8 abrogates its promotion of cervical cancer growth and metastasis[J]. Mol Cell Biochem, 2013, 375(1-2): 69-79
[46] Li S, Crothers J, Haqq CM, et al. Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA[J]. J Biol Chem, 2005, 280(25): 23709-23717
[47] Gong H, Song L, Lin C, et al. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma[J]. Clin Cancer Res, 2013, 19(5): 1083-1093
[48] Bhatia S, Kaul D, Varma N. Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia[J]. Mol Cell Biochem, 2010, 340(1-2): 97-106
[49] Middleton G, Silcocks P, Cox T, et al. Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial[J]. Lancet Oncol, 2014, 15(8): 829-840
[50] Menez-Jamet J, Gallou C, Rougeot A, et al. Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines[J]. Ann Transl Med, 2016, 4(14): 266